ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition)

Tampa, FL (ISPE Global HQ)
Airborne Particle Sampling Containment Performance Testing HPAPI Containment Evaluation Surrogate-Based Sampling
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition)

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Tampa, FL (ISPE Global HQ)
Modalities
Airborne Particle Sampling, Containment Performance Testing, HPAPI Containment Evaluation, Surrogate-Based Sampling
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAirborne Particle Sampling, Containment Performance Testing, HPAPI Containment Evaluation, Surrogate-Based Sampling
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (4 modalities)

Frequently Asked Questions About ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition)

What is ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition)'s CDMO Signal Score?
ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition) for a manufacturing program?
Use the free AI matchmaker to compare ISPE Good Practice Guide: SMEPAC – Standardized Methodology for Evaluation of Pharmaceutical Airborne Particle Emissions (3rd Edition) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
HPAPI Containment Evaluation CDMOs →